| Gene ID | Annotation | Scaffold | Start | End | Strand |
|---|---|---|---|---|---|
| Bpl_scaf_30030-1.12 | PDZ AND LIM DOMAIN PROTEIN ZASP | Bpl_scaf_30030 | 146747 | 171807 | - |
| CDS | |||||
| Bpl_scaf_30030-1.12 | |||||
| Transcript |
| Bpl_scaf_30030-1.12 |
| Protein |
| Bpl_scaf_30030-1.12 |
| Gene family | Subfamily |
|---|---|
| - | - |
| Pfam accession | Pfam name | Description | Type | Source |
|---|---|---|---|---|
| PF00412 | LIM | LIM domain | Domain | Interproscan |
| PF03535 | Paxillin | Paxillin family | Family | Interproscan |
| InterPro term | Type | Description | Source |
|---|---|---|---|
| IPR001781 | Domain | Zinc finger, LIM-type | Interproscan |
| IPR001904 | Domain | Paxillin, Lim domain 4 | Interproscan |
| IPR047075 | Domain | Paxillin/TGFB1I1, LIM domain 1 | Interproscan |
| IPR050604 | Family | PDZ and LIM domain-containing | Interproscan |
| PANTHER term | Description | Source |
|---|---|---|
| PTHR24214 | PDZ AND LIM DOMAIN PROTEIN ZASP | Interproscan |
| GO terms | Category | Description | Source |
|---|---|---|---|
| - | - | - | - |
| KO | Enzyme | Enzyme ID | pathway | mapID | Source |
|---|---|---|---|---|---|
| K05760 | PXN; paxillin | - | VEGF signaling pathway | ko04370 | PMID: 28812709 |
| Focal adhesion | ko04510 | PMID: 28812709 | |||
| Regulation of actin cytoskeleton | ko04810 | PMID: 28812709 | |||
| Leukocyte transendothelial migration | ko04670 | PMID: 28812709 | |||
| Chemokine signaling pathway | ko04062 | PMID: 28812709 | |||
| Proteoglycans in cancer | ko05205 | PMID: 28812709 | |||
| Viral carcinogenesis | ko05203 | PMID: 28812709 | |||
| Bacterial invasion of epithelial cells | ko05100 | PMID: 28812709 | |||
| Human papillomavirus infection | ko05165 | PMID: 28812709 |
| 1. Expression trend for Bpl_scaf_30030-1.12 global RNA-seq network |
Maintained by Dr. Jiajie She in Longjun Wu's Lab & Pei-yuan Qian's Lab and supported by Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou) & The Hong Kong University of Science and Technology
© 2024 All Rights Reserved.
